Budapest Post

Cum Deo pro Patria et Libertate
Budapest, Europe and world news

US officials may need 2 weeks or more to determine if Johnson & Johnson's vaccine causes rare blood clots

US officials may need 2 weeks or more to determine if Johnson & Johnson's vaccine causes rare blood clots

The CDC still might not have enough data to evaluate a blood clot link by its Friday meeting, two senior health officials told Politico.

US federal agencies may need two weeks or more to know whether Johnson & Johnson's coronavirus vaccine is linked to rare blood clots, two senior White House health officials told Politico on Saturday.

US regulators recommended a pause in the distribution of J&J's shot last Tuesday due to six reports of clotting among women who'd recently received the vaccine.

The particular blood clot in question, central venous sinus thrombosis (CVST), forms in the brain — so it can lead to headaches or stroke. In an average year, the condition occurs in about five people out of every million.

The Centers for Disease Control and Prevention's vaccine advisory panel is scheduled to convene Friday to discuss whether to lift the vaccine pause. But two health officials told Politico that the CDC still might not have enough data by then to determine if J&J's vaccine indeed causes rare clots.

US regulators may ultimately consider placing age- or gender-based restrictions on the shot, which has been authorized for people ages 18 and older. Alternatively, regulators could simply deliver stronger warnings about possible blood clots in unusual cases.

Many political leaders and medical experts worry that if regulators take too long to evaluate the potential blood clot link, an increasing share of Americans will lose trust in J&J's vaccine.

"The longer the pause is, the longer it's going to take for us to convince people that this particular vaccine is safe again," Arkansas Gov. Asa Hutchinson told Politico.

Peter Gulick, an associate professor of medicine at Michigan State University, said the J&J pause could delay the prospect of herd immunity — the threshold beyond which the virus won't be able to pass easily from person to person.

"The fear is that, hearing all this, the anti-vaxxers and even the ones on the fence are falling off the fence now into the arena of 'I don't think I want to get any vaccine until things are known a little more,'" Gulick told Insider. "We may have taken two steps backwards as far as our wanting to get herd immunity."

Searching for blood clots in a 'muddied water' of data


Johnson & Johnson's coronavirus vaccine is delivered as a single shot, while both Pfizer's and Moderna's require two jabs.


The CDC's vaccine advisory panel has already met once to review the rare blood clot cases. At a meeting last Wednesday, the panel recommended continuing the pause on J&J's vaccine until more data could be gathered.

"It's important from the perspective of the public: When we say rare, what does that mean?" Dr. Beth Bell, a professor of global health at the University of Washington, said during the meeting. "I want to be able to feel comfortable with my family members and myself getting this vaccine."

US regulators are now encouraging doctors to report any post-vaccination CVST cases over the last few weeks. Regulators are also working with Johnson & Johnson to find out more about the six reported cases — in particular, whether the women had underlying health problems or were taking any medications that could have predisposed them to clotting.

So far, regulators have noticed a few patterns: The women were between the ages of 18 and 48. They also had a rare combination of CVST and low levels of platelets — colorless blood cells that help clots form.

Before the vaccines were authorized, this combination was primarily seen in association with the blood-thinning drug heparin. In rare cases, people taking the medication develop antibodies that bind to a specific platelet, which can make them more susceptible to clots.

"This observation of the low platelet count is part of the mystery and something that has to be worked through to see if that's connected or not," Namandjé Bumpus, director of the pharmacology and molecular sciences department at Johns Hopkins Medicine, told Insider.

But medical experts stressed the need for more data before associating the clots with any particular group yet.

"Everything is just like a big muddied water and then you just try to clear things out as much as you can to try to evaluate what is going on," Gulick said.

Vaccinations may slow for the homeless, prisoners, or rural Americans


Yvonne Gibbs, 72, receives Moderna's COVID-19 vaccine, at the TCF Center in Detroit.


Shortly after US regulators announced a pause in J&J's vaccine, White House COVID-19 coordinator Jeff Zients said the recommendation wouldn't affect the pace of the US vaccine rollout.

"We have more than enough supply of Pfizer and Moderna vaccines to continue the current pace of about 3 million shots per day," Zients said at a Tuesday press briefing.

Indeed, many health departments, pharmacies, and vaccine clinics that planned on administering Johnson & Johnson were able to quickly procure other shots so people didn't lose their appointments.

But some vaccination sites — particularly those in rural areas — were forced to shut down temporarily. A state-run mass vaccination site in Aurora, Illinois, was canceled earlier this week, terminating appointments of 1,000 people. Around the same time, a Johnson & Johnson clinic in Jefferson County, Illinois, put vaccinations on hold.

The J&J pause has also slowed the pace of vaccinations for homeless people, prisoners, and those unable to leave their homes due to illness or old age. J&J's vaccine is the only single-dose shot authorized in the US, so it's the easiest to administer. It's also easier to store than the Pfizer or Moderna vaccines (it can be kept in standard refrigerators rather than freezers).

On top of that, people may gravitate toward J&J's vaccine if they're afraid of needles or have difficulty taking time off work to get vaccinated.

"We're actually seeing that some people opt for the Johnson and Johnson shot just because of their circumstances — it's one dose, it's available, and so on," Johan Bester, director of bioethics at the University of Nevada, Las Vegas School of Medicine, told Insider.

Without the J&J option, medical experts said, US health officials may have a harder time convincing more Americans to get vaccinated — even as new, more contagious variants drive up cases across the country.

AI Disclaimer: An advanced artificial intelligence (AI) system generated the content of this page on its own. This innovative technology conducts extensive research from a variety of reliable sources, performs rigorous fact-checking and verification, cleans up and balances biased or manipulated content, and presents a minimal factual summary that is just enough yet essential for you to function as an informed and educated citizen. Please keep in mind, however, that this system is an evolving technology, and as a result, the article may contain accidental inaccuracies or errors. We urge you to help us improve our site by reporting any inaccuracies you find using the "Contact Us" link at the bottom of this page. Your helpful feedback helps us improve our system and deliver more precise content. When you find an article of interest here, please look for the full and extensive coverage of this topic in traditional news sources, as they are written by professional journalists that we try to support, not replace. We appreciate your understanding and assistance.
Newsletter

Related Articles

0:00
0:00
Close
Altman Says GPT-5 Already Outpaces Him, Warns AI Could Automate 40% of Work
Russian Research Vessel 'Yantar' Tracked Mapping Europe’s Subsea Cables, Raising Security Alarms
Global Cruise Industry Posts Dramatic Comeback with 34.6 Million Passengers in 2024
U.S. Demands Brussels Scrutinize Digital Rules to Prevent Bias Against American Tech
Private Equity’s Fundraising Surge Triggers Concern of European Market Shake-Out
Tokyo’s Jimbōchō Named World’s Coolest Neighbourhood for 2025
European Officials Fear Trump May Shift Blame for Ukraine War onto EU
The Personality Rights Challenge in India’s AI Era
Italy Considers Freezing Retirement Age at 67 to Avert Scheduled Hike
Italian City to Impose Tax on Visiting Dogs Starting in 2026
Study Finds No Safe Level of Alcohol for Dementia Risk
Trump Says Ukraine Can Fully Restore Borders with NATO Backing
Europe Signals Stronger Support for Taiwan at Major Taipei Defence Show
Germany Weighs Excluding France from Key European Fighter Jet Programme
Cyberattack Disrupts Check-in and Boarding Systems at Major European Airports
Björn Borg Breaks Silence: Memoir Reveals Addiction, Shame and Cancer Battle
When Extremism Hijacks Idealism: How the Baader-Meinhof Gang Emerged and Fell
JWST Data Brings TRAPPIST-1e Closer to Earth-Like Habitability
Trump Orders $100,000 Fee on H-1B Visas and Launches ‘Gold Card’ Immigration Pathway
France’s Looming Budget Crisis and Political Fracture Raise Fears of Becoming Europe’s “Sick Man”
Three Russian MiG-31 Jets Breach Estonian Airspace in ‘Unprecedentedly Brazen’ NATO Incident
European manufacturers against ban on polluting cars: "The industry may collapse"
Turkish car manufacturer Togg Enters German Market with 5-Star Electric Sedan and SUV to Challenge European EV Brands
Christian Brueckner Released from German Prison after Serving Unrelated Sentence
World’s Longest Direct Flight China Eastern to Launch 29-Hour Shanghai–Buenos Aires Direct Flight via Auckland in December
New OpenAI Study Finds Majority of ChatGPT Use Is Personal, Not Professional
The conservative right spreads westward: a huge achievement for 'Alternative for Germany' in local elections
Pope Leo Warns of Societal Crisis Over Mega-CEO Pay, Citing Tesla’s Proposed Trillion-Dollar Package
Poland Green-Lights NATO Deployment in Response to Major Russian Drone Incursion
U.S. and China Agree on Framework to Shift TikTok to American Ownership
Le Pen Tightens the Pressure on Macron as France Edges Toward Political Breakdown
Czech Republic signs €1.34 billion contract for Leopard 2A8 main battle tanks with delivery from 2028
Penske Media Sues Google Over “AI Overviews,” Claiming It Uses Journalism Without Consent and Destroys Traffic
Indian Student Engineers Propose “Project REBIRTH” to Protect Aircraft from Crashes Using AI, Airbags and Smart Materials
One in Three Europeans Now Uses TikTok, According to the Chinese Tech Giant
Could AI Nursing Robots Help Healthcare Staffing Shortages?
NATO Deploys ‘Eastern Sentry’ After Russian Drones Violate Polish Airspace
The New Life of Novak Djokovic
German police raid AfD lawmaker’s offices in inquiry over Chinese payments
Volkswagen launches aggressive strategy to fend off Chinese challenge in Europe’s EV market
France Erupts in Mass ‘Block Everything’ Protests on New PM’s First Day
Poland Shoots Down Russian Drones in Airspace Violation During Ukraine Attack
Apple Introduces Ultra-Thin iPhone Air, Enhanced 17 Series and New Health-Focused Wearables
Macron Appoints Sébastien Lecornu as Prime Minister Amid Budget Crisis and Political Turmoil
Vatican hosts first Catholic LGBTQ pilgrimage
Apple Unveils iPhone 17 Series, iPhone Air, Apple Watch 11 and More at 'Awe Dropping' Event
France joins Eurozone’s ‘periphery’ as turmoil deepens, say investors
France Faces New Political Crisis, again, as Prime Minister Bayrou Pushed Out
Nayib Bukele Points Out Belgian Hypocrisy as Brussels Considers Sending Army into the Streets
France, at an Impasse, Heads Toward Another Government Collapse
×